[44]
The applicant refers to an article written by Novopharm's expert, Dr. Caldwell, entitled "Putting Chirality to Work: The Strategy of Chiral Switches", wherein he recognized that in pairs of enantiomers in racemic mixtures it is uncertain which enantiomer is the "antagonist" or "active" one. Janssen stresses, relying on
Bayer Aktiengesellschaft
, supra, that the test for obviousness does not involve testing or experimentation, but rather the mythical, skilled technician is expected to "instantly and spontaneously" know the answer which the patent teaches from the state of knowledge in the art at the date of invention.